Timing of the surgical intervention is also important to keep in mind, said Grob
doi: 10.1007/s40264-013-0038-6 13 FloryJHHennessyS
She also provides ongoing dosing adjustments and monitoring
(Yicai) May 17 -- Chinese drugmaker Hengrui Pharmaceuticals granted the exclusive global rights to its glucagon-like peptide-1 diabetes treatment and weight-loss drug portfolio to a newly established company under US private investment firm Bain Capital
Last reviewed: May 15, 2026 Last updated: May 15, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
However, only a small number of patients were included in the study, and median levels were not elevated even before the commencement of GLP-1 RAs treatment (102)